Bunge Stock Could $134 by Year End, JPMorgan Analyst Says
JPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
This section explains why investors might choose an Equal Weighted Index, focusing on balanced exposure and straightforward rebalancing.
22,679 articlesJPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
FairGambling unveils a new crypto casino review and analytics platform combining on-chain insights, provably fair ver...
A fresh framework shows a simple trio of ETFs may match the glide-path goals of target-date funds for those planning ...
Alibaba's profits falling here's headlines grab attention, but the real story is a company in transition. This guide ...
U.S. lenders are accelerating cash returns to shareholders after stress tests and capital rules ease. JPMorgan, Bank ...
Hydrogen names tumble after a monster 2026 run, led by FuelCell Energy, Bloom Energy, and Plug Power. The market back...
Millrose Properties marks its first year as an independent REIT with solid Q1 2026 earnings, expanding its builder ne...
A cybersecurity ETF surged roughly 40% in the last month, signaling a shift in investor sentiment toward AI-enabled d...
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Trump signals possible U.S. ground action against Mexican cartels, sending ripples through defense stocks and supply ...
In 2026, XMAG has surged while MAGS has slipped, underscoring a shift from mega-cap AI bets to broad-market exposure....
A targeted international dividend fund surged 26% over the past year and yields around 3.1%, while broad overseas exp...